Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line
- PMID: 30658112
- DOI: 10.1016/j.ejphar.2019.01.018
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line
Abstract
Telomerase-mediated immortalization and proliferation of tumor cells is a promising anti-cancer treatment strategy and development of potent telomerase inhibitors is believed to open new window of treatments in human malignancies. In the present study, we found that BIBR1532, a small molecule inhibitor of human telomerase, exerted cytotoxic effects on a panel of human cancer cells spanning from solid tumors to hematologic malignancies; however, as compared with solid tumors, leukemic cells were more sensitive to this inhibitor. This was independent of molecular status of p53 in the leukemic cells. The results of a miRNA PCR array revealed that BIBR1532-induced cytotoxic effects in NB4, the most sensitive cell line, was coupled with alteration in a substantial number of cancer-related miRNAs. Interestingly, most of these miRNAs were found to act as tumor suppressors with validated targets in cell cycle or nuclear factor (NF)-κB-mediated apoptosis. In accordance with a bioinformatics analysis, our experimental studies showed that BIBR1532-induced apoptosis is mediated, at least partly, by inhibition of NF-κB. Moreover, we found that the alteration in the expression of miRNAs was coupled with the alteration in the cell cycle progression. To sum up with, a straightforward interpretation of our results is that telomerase inhibition using BIBR1532 not only induced CDKN1A-mediated G1 arrest in NB4, but also resulted in a caspase-3-dependent apoptotic cell death mostly through suppression of NF-κB axis.
Keywords: BIBR1532; Leukemia; MicroRNA; NF-κB; Telomerase.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.Hematology. 2017 Jul;22(6):330-340. doi: 10.1080/10245332.2016.1275426. Epub 2017 Jan 5. Hematology. 2017. PMID: 28054503
-
Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.J Cell Biochem. 2018 Dec;119(12):9817-9824. doi: 10.1002/jcb.27301. Epub 2018 Aug 26. J Cell Biochem. 2018. PMID: 30145821
-
Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.Leuk Lymphoma. 2013 Mar;54(3):561-8. doi: 10.3109/10428194.2012.704034. Epub 2012 Sep 28. Leuk Lymphoma. 2013. PMID: 22957790
-
Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.Anticancer Drugs. 2008 Apr;19(4):329-38. doi: 10.1097/CAD.0b013e3282f5d4c2. Anticancer Drugs. 2008. PMID: 18454043 Review.
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
Cited by
-
Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.Int J Mol Sci. 2019 Jun 2;20(11):2716. doi: 10.3390/ijms20112716. Int J Mol Sci. 2019. PMID: 31159515 Free PMC article. Review.
-
Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients.BMC Res Notes. 2020 Apr 19;13(1):226. doi: 10.1186/s13104-020-05071-9. BMC Res Notes. 2020. PMID: 32307002 Free PMC article.
-
Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin's Lymphoma Cell Death.Biomedicines. 2022 Sep 16;10(9):2299. doi: 10.3390/biomedicines10092299. Biomedicines. 2022. PMID: 36140400 Free PMC article.
-
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463. Int J Mol Sci. 2024. PMID: 39273409 Free PMC article. Review.
-
Advances in Pediatric Acute Promyelocytic Leukemia.Children (Basel). 2020 Feb 2;7(2):11. doi: 10.3390/children7020011. Children (Basel). 2020. PMID: 32024232 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous